KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Return on Invested Capital (2016 - 2025)

NovoCure (NVCR) has disclosed Return on Invested Capital for 11 consecutive years, with 0.45% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital rose 16.0% to 0.45% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.45% through Dec 2025, up 16.0% year-over-year, with the annual reading at 0.44% for FY2025, 10.0% down from the prior year.
  • Return on Invested Capital hit 0.45% in Q4 2025 for NovoCure, up from 0.6% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q1 2021 to a low of 0.61% in Q4 2024.
  • Historically, Return on Invested Capital has averaged 0.27% across 5 years, with a median of 0.26% in 2023.
  • Biggest five-year swings in Return on Invested Capital: plummeted -34bps in 2024 and later rose 16bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.05% in 2021, then tumbled by -97bps to 0.1% in 2022, then crashed by -165bps to 0.27% in 2023, then crashed by -129bps to 0.61% in 2024, then grew by 26bps to 0.45% in 2025.
  • Business Quant data shows Return on Invested Capital for NVCR at 0.45% in Q4 2025, 0.6% in Q3 2025, and 0.58% in Q2 2025.